Metabolic syndrome (MS) is a growing disorder affecting thousands of people worldwide,
especially in industrialised countries, increasing mortality. Oxidative stress, hyperglycaemia …

Metabolic Syndrome (MetS) is a cluster of risk factors that, taken alone or synergically, are
independent predictors of type 2 diabetes and cardiovascular disease (CVD), which are …

The metabolic syndrome (MS), a cluster of several risk factors for diabetes and
cardiovascular disease, major causes of morbidity and death, is a highly prevalent condition …

Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …

The definition of metabolic syndrome (MetS) has undergone several changes over the years
due to the difficulty in establishing universal criteria for it. Underlying the disorders related to …

Metabolic syndrome (MS) is a chronic non‐infective syndrome characterised clinically by a
set of vascular risk factors that include insulin resistance, hypertension, abdominal obesity …

Metabolic syndrome (MS) is a chronic non-infective syndrome characterised clinically by a
set of vascular risk factors that include insulin resistance, hypertension, abdominal obesity …

The metabolic syndrome (MetS), first introduced by Haller in 1975, was sometimes also
known as insulin resistance syndrome, syndrome X, and plurimetabolic syndrome. In 1989 …

Abstract Significance: Metabolic syndrome (MetS) is associated with a greater risk of
diabetes and cardiovascular diseases. It is estimated that this multifactorial condition affects …

The metabolic syndrome (MetS) is characterized by a cluster of cardiovascular risk factors,
including central obesity, hyperglycemia, dyslipidemia and hypertension, which are highly …